Address of the bookmark: https://github.com/nanoporetech/medaka

Pay Matrix Level-12
No. of Post-01
(UR)
Post – Sr. Scientist
Area Bioinformatics
Age limit : 37 years
PhD in Computational Biology/Bioinformatics with 2 years experience in desired area
Or
ME/M.Tech in Bioinformatics or Genome Informatics or Genetic Engineering with 3 years experience in desired area
Experience of understanding fundamental science behind Artificial Intelligence, machine learning, novel Artificial Intelligence algorithms and architectures, software engineering principles for Artificial Intelligence, natural language processing with proficiency in programming as evident by publications in SCI journals with high impact factor. To be part a group of scientists working in the area of genomics, running the central
bioinformatics facility, developing independent projects and providing bioinformatics support to the user scientists of the Institute.

More at

http://14.139.62.50/CSIR-IITR%20Scientist%20Recruitment%20Adv%202020.pdf

1. Big Data and Bioinformatics

The exponential growth in biological data, driven by advancements in sequencing technologies and high-throughput experiments, has made bioinformatics an indispensable tool. By 2030, we anticipate:

• Petabyte-Scale Data Management: Enhanced storage solutions and cloud computing platforms will allow researchers to handle the vast amounts of data generated from omics studies, including genomics, transcriptomics, and proteomics.

• AI and Machine Learning Integration: Sophisticated algorithms will uncover patterns and relationships in large datasets, enabling predictions about gene function, disease susceptibility, and therapeutic outcomes.

2. Personalized Medicine and Genomics

Bioinformatics will play a pivotal role in tailoring healthcare to individual patients. Key developments include:

• Whole-Genome Sequencing in Clinics: The decreasing cost of sequencing will make it routine in medical diagnostics, enabling personalized treatment plans based on an individual’s genetic makeup.

• Drug Repurposing and Development: Computational tools will identify potential new uses for existing drugs, accelerating the development of targeted therapies.

3. Advancing Computational Tools

The future will see the development of more user-friendly and powerful bioinformatics tools:

• Graph-Based Approaches: Enhanced algorithms for analyzing complex biological networks, such as protein-protein interaction maps.

• Visualization Tools: Intuitive software for visualizing multi-dimensional data, enabling researchers to interpret findings more effectively.

4. Synthetic Biology and Systems Biology

Bioinformatics will continue to drive progress in synthetic and systems biology by:

• Gene Circuit Design: Leveraging computational models to design and simulate synthetic biological systems.

• Understanding Cellular Pathways: Integrating multi-omics data to model cellular processes with unprecedented accuracy.

5. Bioinformatics in Agriculture and Environmental Science

Beyond healthcare, bioinformatics will revolutionize agriculture and environmental conservation:

• Crop Improvement: Genomic studies will help develop high-yield, disease-resistant, and climate-resilient crops.

• Microbial Ecology: Metagenomics will enhance our understanding of microbial communities, aiding in bioremediation and ecosystem management.

6. Democratization of Bioinformatics

Open-source software and accessible education will broaden participation in bioinformatics research:

• Community-Driven Projects: Collaborative platforms like GitHub will continue to foster innovation in tool development.

• Education and Training: Online courses and workshops will bridge skill gaps, enabling researchers from diverse backgrounds to contribute.

Challenges and Ethical Considerations

While the future is bright, challenges remain. Data privacy and ethical concerns surrounding genetic information require careful navigation. Furthermore, addressing the digital divide is critical to ensuring equitable access to bioinformatics resources globally.

Conclusion

The future of bioinformatics is boundless, with opportunities to revolutionize our understanding of life and improve human health. As technologies evolve and collaborations flourish, bioinformatics will undoubtedly remain at the forefront of scientific discovery, unlocking the secrets of life one dataset at a time.

BioCoder features:

• Novel therapeutic discovery strategies
• Hardware such as low-cost lab equipment or diagnostics
• Open or low­-cost bioinformatics tools
• Engineered organisms for the production of small molecules, biologics, or other products
• Research projects at a community labspace or projects for science education or public engagement
• Hardware or software for lab automation
• Citizen science or DIY research projects
• Science policy
• Tools to increase reproducibility in research, or anything related

Address of the bookmark: https://www.oreilly.com/biocoder/

During the first phase of ENCODE, published in 2007, microarray-based technologies were used to detect regions associated with transcription factors, certain histone modifications and open chromatin within a pre-specified 1% of the human genome.

ENCODE’s second phase saw a switch to sequencing-based technologies, the addition of new assay types and the analysis of functional elements genome-wide, described in a collection of research articles in 2012.

The Encyclopedia paper of ENCODE 3, published in Nature, gives an overview of the various assays that were performed in human and mouse cell lines and tissues and describes a Registry of human and mouse candidate cis-regulatory elements (cCREs).

More at https://www.nature.com/immersive/d42859-020-00027-2/index.html

1. NCBI (National Center for Biotechnology Information):

   • NCBI provides various databases related to genetic information, including 16S rRNA sequences.
   • You can access the 16S ribosomal RNA sequences from NCBI's Nucleotide database (https://www.ncbi.nlm.nih.gov/nucleotide/).
   • Perform a search using keywords like "16S rRNA" or specific bacterial names to find relevant sequences.
   • You can download sequences individually or in batches using the provided tools.

2. GreenGenes:

   • GreenGenes is a widely used 16S rRNA gene sequence database.
   • You can access it at http://greengenes.secondgenome.com/.
   • GreenGenes provides precompiled databases for various purposes, including classification, alignment, and phylogenetic analysis.

3. SILVA:

   • SILVA (https://www.arb-silva.de/) is another comprehensive database for ribosomal RNA (rRNA) sequences.
   • It covers not only 16S rRNA but also other ribosomal RNA sequences.
   • SILVA provides precompiled databases for various purposes, including taxonomic classification and alignment.

4. Ribosomal Database Project (RDP):

   • RDP (http://rdp.cme.msu.edu/) is a curated database that offers 16S rRNA sequences.
   • It provides tools for sequence analysis and classification.
   • You can download sequences and taxonomy information from their website.

5. QIIME (Quantitative Insights Into Microbial Ecology):

   • QIIME (https://qiime2.org/) is a widely used bioinformatics platform for microbiome analysis.
   • It provides tools for analyzing microbial communities, including processing 16S rRNA sequences.
   • QIIME often includes its own preprocessed 16S rRNA databases that can be used for analysis within the platform.

Before downloading any database, make sure to read the terms of use and citation requirements, as some databases may have specific usage policies. Additionally, consider the compatibility of the database with your analysis pipeline and software tools.

NCBI 16s RNA database location ftp://ftp.ncbi.nih.gov/blast/db/16SMicrobial.tar.gz

Aim of this web site is to facilitate the scientific community to fight against severe pandemic disease COVID-19 caused by SARS-CoV-2. Here, We have collected and organized information related to novel strain of coronavirus, i.e. SARS-CoV-2.and its resulting disease COVID-19 from the literature and other resources from the Internet. We are providing links to appropriate literature. Moreover, we are Bioinformatics Group, based on our knowledge and expertise, we are also proposing potential diagnostics primers, peptide and RNA based vaccine candidates and potential drug molecules. These are predicted candidates, need to be validated by experimental Researchers, who have appropriate infrastructure. It is an integrated multi-omics repository dedicated to current genomic, proteomic, diagnostic and therapeutic knowledge about coronaviruses particularly the recent strain, i.e. SARS-CoV-2 or 2019-nCoV. This web resource will be helpful for the researchers engaged in the development of therapies and drugs for the COVID-19. The information is collected from various available resources.
Cite: Patiyal, Sumeet, et al. “A Web-based Platform on COVID-19 to Maintain Predicted Diagnostic, Drug
and Vaccine Candidates.” Monoclon Antib Immunodiagn Immunother. doi.org/10.1089/mab.2020.0035

Address of the bookmark: https://webs.iiitd.edu.in/raghava/coronavir/

Address of the bookmark: http://scikit-bio.org/

• dbCAN provides the capability of automated and comprehensive CAZyme annotation of a given genome submitted by the user;
• dbCAN provides an explicitly defined signature domain for each and every CAZyme family along with its location in all the relevant full-length CAZyme proteins in all sequenced genomes;
• dbCAN provides the most complete set of metagenomic CAZyme genes published so far and represents the first step towards discovering novel CAZyme catalysts in metagenomes;
• dbCAN provides a subfamily classification of the existing CAZyme families based on sequence similarities;
• dbCAN make all pre-computed data freely available to the public, including sequence alignments, hidden markov models (HMMs) and phylogenies of the signature domain regions in each and every CAZyme family and subfamily.

dbCAN is updated regularly when CAZy database created new families based on latest literature.

Address of the bookmark: http://csbl.bmb.uga.edu/dbCAN/index.php